Brief: Virpax Reports Successful Results Of Toxicology And Pharmacokinetic Study For Epoladerm

Virpax Pharmaceuticals

08/12/2021 13:07

Dec 8 (Reuters) - Virpax Pharmaceuticals Inc  VRPX.O :
    * VIRPAX REPORTS SUCCESSFUL RESULTS OF TOXICOLOGY AND
PHARMACOKINETIC STUDY FOR EPOLADERM™
    * VIRPAX PHARMACEUTICALS INC - SINGLE-DOSE TRANSDERMAL
DELIVERY OF
EPOLADERM WAS WELL-TOLERATED IN ALL MINIPIGS
    * VIRPAX PHARMACEUTICALS INC - NO TREATMENT-RELATED CLINICAL
OBSERVATIONS, CHANGES IN BODY WEIGHT, OR DERMAL IRRITATION WERE
OBSERVED.
    * VIRPAX PHARMACEUTICALS INC - ALL EPOLADERM TREATED ANIMALS
HAD
PLASMA LEVELS OF EPOLADERM CONFIRMING TRANSDERMAL ABSORPTION
    * VIRPAX PHARMACEUTICALS INC - DATA SHOULD STRENGTHEN
COMPANY'S
IND FILING IN ADVANCE OF ANTICIPATED START OF FIRST-IN-HUMAN
CLINICAL TRIALS.

Source text for Eikon:  ID:nBwbFRK08a 
Further company coverage:  VRPX.O 

 ((Reuters.Briefs@thomsonreuters.com;))